Prothena Corporation plc (Nasdaq: PRTA) is a late-stage clinical biotechnology company with expertise in protein dysregulation and a diverse pipeline of ...
Latest Events & Presentations ; March 12, 2024 10:00 AM ET. Leerink Partners Global Biopharma Conference ; February 15, 2024 4:30 PM ET. Prothena Fourth Quarter ...
Find the latest SEC Filings data for Prothena Corporation plc Ordinary Shares (PRTA) including 10-K and 10-Q forms at Nasdaq.com.
People also ask
What is the annual revenue of Prothena?
What does Prothena do?
Find the latest institutional holdings data for Prothena Corporation plc Ordinary Shares (PRTA) including shareholders, ownership summaries, ...
Feb 16, 2024 · Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings ... presentation over to Mark Johnson, Vice President of Investor Relations at Prothena.
Prothena Corporation plc (PRTA) Q4 2022 Earnings Call Transcript · SA TranscriptsFri, Feb. 24, 2023. Prothena Corporation (PRTA) Investor Presentation - ...
Missing: relations | Show results with:relations
Prothena Corporation plc (US:PRTA) has 447 institutional owners and shareholders ... Investor Shares, FDGRX ... relation to this website or the information and ...
Get Prothena Corporation PLC (PRTA.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
Missing: investor relations
See the company profile for Prothena Corporation plc (PRTA) including business summary, industry/sector information, number of employees, business summary, ...
PRTA | Complete Prothena Corp. PLC stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Missing: relations | Show results with:relations